Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
209.6 USD | +0.01% | -3.29% | -0.46% |
03:11am | Australian shares fall as miners and banks drag; Fed in focus | RE |
Apr. 30 | Surging Wage Growth Drags US Equity Indexes Lower, Treasury Yields Higher Ahead of Fed Policy Statement | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company is one of the best yield companies with high dividend expectations.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The firm trades with high earnings multiples: 22.03 times its 2024 earnings per share.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Financial & Commodity Market Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.46% | 75.48B | B | ||
+11.92% | 21.67B | C+ | ||
+19.24% | 12.06B | C+ | ||
+41.76% | 8.47B | C+ | ||
-0.40% | 8.01B | B- | ||
+25.61% | 4.53B | C | ||
-2.16% | 3B | C+ | ||
+28.41% | 2.51B | C | ||
-6.96% | 1.67B | C | ||
+77.47% | 1.31B | - | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CME Stock
- Ratings CME Group Inc.